Related Experiment Video
Updated: Mar 14, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
The Downside of Fat: Avoiding and Treating Complications
Irene A Kim1, Gregory Keller1, Michael J Groth2
1Division of Facial Plastic Surgery, Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California.
Facial Plastic Surgery : FPS
|September 30, 2016
Summary
Autologous fat grafting is a popular facial rejuvenation technique. This article systematically reviews potential complications and offers strategies for avoidance and treatment to ensure patient safety.
Area of Science:
- Plastic Surgery
- Regenerative Medicine
- Aesthetic Dermatology
Background:
- Autologous fat grafting is a widely accepted method for facial volume restoration and rejuvenation.
- Fat grafts offer benefits such as being nonallergenic and versatile for various facial enhancements.
- Despite its advantages, autologous fat grafting carries risks of complications.
Purpose of the Study:
- To systematically present complications associated with each step of autologous fat grafting in facial rejuvenation.
- To provide practical pearls for avoiding and managing these potential complications.
Main Methods:
- Systematic review of potential complications in facial fat grafting.
- Analysis of each procedural step to identify risk factors.
- Compilation of expert recommendations for complication management.
Main Results:
- Detailed description of complications encountered during fat harvesting, processing, and injection.
- Identification of specific techniques to minimize risks like infection, contour irregularities, and vascular compromise.
- Strategies for managing common adverse events.
Conclusions:
- Autologous fat grafting is effective for facial rejuvenation but requires meticulous technique to mitigate risks.
- A systematic approach to understanding and managing complications is crucial for successful outcomes.
- Adherence to best practices enhances patient safety and satisfaction in facial fat grafting procedures.
Related Concept Videos
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
343
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
343
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
262
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
262
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:21Drug Dosing: Obese Patients
325
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325